Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleRadiobiology/Dosimetry

Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation

Catherine A. Foss, Donika Plyku, Alvaro A. Ordonez, Julian Sanchez-Bautista, Hailey B. Rosenthal, Il Minn, Martin A. Lodge, Martin G. Pomper, George Sgouros and Sanjay K. Jain
Journal of Nuclear Medicine November 2018, 59 (11) 1751-1756; DOI: https://doi.org/10.2967/jnumed.117.207431
Catherine A. Foss
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donika Plyku
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvaro A. Ordonez
2Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
3Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian Sanchez-Bautista
2Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
3Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hailey B. Rosenthal
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Il Minn
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin A. Lodge
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin G. Pomper
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Sgouros
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay K. Jain
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
3Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Maximum-intensity projections of biodistribution at 4–72 h after injection in 2 representative subjects. (A) At 4 h after injection, radiotracer uptake is primarily in heart, liver, salivary tissues, and bone marrow, and gastrointestinal clearance is readily observable. At 24 and 48 h, retention is reduced in all tissues except gastrointestinal tract. (B) At 24–72 h after injection, clearance is seen from most tissues but is slower from bone marrow and salivary tissues. However, signal in gastrointestinal tract is visible through 72 h. %ID/cc = percentage injected dose per cubic centimeter of tissue. GI = gastrointestinal tract; H = heart; L = liver; M = bone marrow; S = salivary tissues.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Biodistribution in lungs and mediastinum 4–72 h after injection as seen on transaxial PET/CT images from subjects A and B of Figure 1. Mediastinal uptake is low in A (arrows) but absent from B. %ID/cc = percentage injected dose per cubic centimeter of tissue.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Mean and SD for physical decay–corrected biodistribution (biodistribution assuming no physical decay of radionuclide) on days 1, 2, and 3. %ID/g = percentage injected dose per cubic centimeter of tissue.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Mean and SD for organ-absorbed doses. LLI = lower large intestine; ULI = upper large intestine.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Subject Characteristics

    Subject no.Age (y)TSPO genotypeWeight (kg)Height (in*)BMIInjected activity (MBq)Injected mass (ng)
    F164C/T106.16242.869.2461
    F243C/T97.56338.171.6476
    F322C/C65.86524.178.1520
    M159C/T78.07322.771.6477
    M228C/T76.771.523.269.9466
    M322C/C71.77221.462.4416
    Mean ± SD40 ± 1982.6 ± 15.768 ± 528.7 ± 9.270.5 ± 5.1469 ± 34
    • ↵* 1 in = 2.54 cm.

    • BMI = body mass index; C/T = medium-affinity binder; C/C = high-affinity binder.

    • View popup
    TABLE 2

    TIACs

    SiteTIAC (h)
    Brain0.275 ± 0.136
    Lungs1.647 ± 0.981
    Spleen0.267 ± 0.170
    Kidneys0.386 ± 0.120
    Gallbladder0.073 ± 0.042
    Liver5.766 ± 3.170
    Heart wall0.423 ± 0.175
    Bladder0.738 ± 0.219
    Pancreas0.096 ± 0.041
    Red marrow3.698 ± 1.048
    Adrenal glands0.014 ± 0.008
    Small intestine1.363 ± 0.499
    Breasts0.195 ± 0.054
    Testes0.029 ± 0.015
    Thyroid0.048 ± 0.025
    Large intestine1.727 ± 0.849
    Thymus0.018 ± 0.008
    Muscle15.191 ± 4.921
    Stomach wall0.309 ± 0.212
    Uterus0.083 ± 0.019
    Ovaries0.015 ± 0.010
    Whole body59.844 ± 18.115
    Remainder of body27.676 ± 18.748
    • Data are mean ± SD.

    • View popup
    TABLE 3

    Absorbed Dose Estimates

    SiteEstimate (mGy/MBq)
    Adrenals0.418 ± 0.143
    Brain0.122 ± 0.064
    Breasts0.181 ± 0.074
    Gallbladder wall0.480 ± 0.136
    Lower large intestinal wall0.709 ± 0.105
    Small intestine0.571 ± 0.117
    Stomach wall0.394 ± 0.134
    Upper large intestinal wall0.681 ± 0.102
    Heart wall0.472 ± 0.201
    Kidneys0.448 ± 0.139
    Liver0.924 ± 0.501
    Lungs0.470 ± 0.243
    Muscle0.276 ± 0.090
    Ovaries0.409 ± 0.177
    Pancreas0.442 ± 0.154
    Red marrow0.446 ± 0.151
    Osteogenic cells0.481 ± 0.243
    Skin0.179 ± 0.095
    Spleen0.463 ± 0.246
    Testes0.218 ± 0.069
    Thymus0.312 ± 0.108
    Thyroid0.438 ± 0.204
    Urinary bladder wall0.618 ± 0.204
    Uterus0.367 ± 0.131
    Total body0.315 ± 0.125
    Effective dose (mSv/MBq)0.459 ± 0.127
    • Data are mean ± SD.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (11)
Journal of Nuclear Medicine
Vol. 59, Issue 11
November 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation
Catherine A. Foss, Donika Plyku, Alvaro A. Ordonez, Julian Sanchez-Bautista, Hailey B. Rosenthal, Il Minn, Martin A. Lodge, Martin G. Pomper, George Sgouros, Sanjay K. Jain
Journal of Nuclear Medicine Nov 2018, 59 (11) 1751-1756; DOI: 10.2967/jnumed.117.207431

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation
Catherine A. Foss, Donika Plyku, Alvaro A. Ordonez, Julian Sanchez-Bautista, Hailey B. Rosenthal, Il Minn, Martin A. Lodge, Martin G. Pomper, George Sgouros, Sanjay K. Jain
Journal of Nuclear Medicine Nov 2018, 59 (11) 1751-1756; DOI: 10.2967/jnumed.117.207431
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiobiology/Dosimetry

  • Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
  • γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
  • Dose–Effect Relationships of 166Ho Radioembolization in Colorectal Cancer
Show more Radiobiology/Dosimetry

Clinical

  • Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
  • γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
  • Dose–Effect Relationships of 166Ho Radioembolization in Colorectal Cancer
Show more Clinical

Similar Articles

Keywords

  • pyrazolopyrimidine
  • macrophage
  • DPA-713
  • sarcoidosis
  • PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire